ArticleNPJ breast cancer2019

Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy.

Theodossis A Theodossiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.